|
KIAA0240 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.351600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.466100E-02 |
| Normal-vs-Stage2 |
8.811400E-01 |
| Normal-vs-Stage3 |
4.254200E-01 |
| Normal-vs-Stage4 |
5.155700E-03 |
| Stage1-vs-Stage2 |
2.421800E-01 |
| Stage1-vs-Stage3 |
7.751800E-01 |
| Stage1-vs-Stage4 |
4.253800E-01 |
| Stage2-vs-Stage3 |
4.856800E-01 |
| Stage2-vs-Stage4 |
1.096440E-01 |
| Stage3-vs-Stage4 |
2.817800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.009160E-01 |
| Normal-vs-AfricanAmerican |
1.438370E-01 |
| Normal-vs-Asian |
5.421000E-04 |
| Caucasian-vs-AfricanAmerican |
8.793400E-01 |
| Caucasian-vs-Asian |
1.905570E-02 |
| AfricanAmerican-vs-Asian |
1.469180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.476000E-02 |
| Normal-vs-Female |
7.021200E-01 |
| Male-vs-Female |
2.304200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.413600E-02 |
| Normal-vs-Extreme_Weight |
7.087700E-02 |
| Normal-vs-Obese |
5.806200E-01 |
| Normal-vs-Extreme_Obese |
3.776200E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.511800E-01 |
| Normal_Weight-vs-Obese |
1.267960E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.143800E-01 |
| Extreme_Weight-vs-Obese |
2.429200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.469600E-01 |
| Obese-vs-Extreme_Obese |
1.297190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.818400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.552800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.551600E-02 |
| Normal-vs-Age(81-100Yrs) |
1.225610E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.806800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.240800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.101230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.144780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.535900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.403800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.745000E-01 |
| Normal-VS-Type2 PRCC |
9.315100E-03 |
| Normal-VS-KIRP CIMP |
1.267560E-01 |
| Normal-VS-Unclassified PRCC |
5.762200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.706300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.313600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.972200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.596200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.863390E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.937000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.195400E-03 |
| Normal-vs-N1 |
5.558600E-01 |
| Normal-vs-N2 |
2.042800E-03 |
| N0-vs-N1 |
1.650980E-01 |
| N0-vs-N2 |
4.918300E-02 |
| N1-vs-N2 |
5.620500E-03 |
|
|
